Article Text

Download PDFPDF
A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma
  1. A. Ayhan*,
  2. R. A. Al*,
  3. C. Baykal*,
  4. E. Demirtas*,
  5. K. YÜCE* and
  6. A. Ayhan
  1. * Department of Obstetrics and Gynecology, Hacettepe University Hospitals, Ankara, Turkey
  2. Department of Pathology, Hacettepe University Hospitals, Ankara, Turkey
  1. Address correspondence and reprint requests to: Professor Dr Ali Ayhan, Hacettepe University School of Medicine, Department of Gynecologic and Oncology, Gynecologic Oncology Unit, 06100 Sihhye, Ankara, Turkey. Email: cem.baykal{at}ttnet.net.tr

Abstract

Objectives: The objective of this study was to compare clinical and pathologic variables and prognosis of FIGO stage IB adenocarcinoma and squamous cell carcinoma of uterine cervix.

Methods A retrospective review was performed of 521 patients with stage IB squamous cell carcinoma and adenocarcinoma of cervix who treated primarily by type 3 hysterectomy and pelvic and/or para-aortic lymphadenectomy at Hacettepe University Hospitals between 1980 and 1997.

Results Age, tumor size, grade, depth of invasion, lymph node metastasis, parametrial, vaginal, and lymphvascular space involvement (LVSI) were not different between two cell types except number of the lymph nodes involved. Metastasis to three or more lymph nodes was significantly higher in adenocarcinoma. Overall and disease-free survival were 87.7%, 84.0% versus 86.4%, 83.1% for squamous cell carcinoma and adenocarcinoma, respectively (P > 0.05). The rate and site of recurrence were not different between two cell types. Multivariate analysis of disease-free and overall survival revealed independent prognostic factors as tumor size, LVSI, number of involved lymph node, and vaginal involvement.

Conclusion Prognosis of FIGO stage IB cervical cancer patients who were treated by primarily radical surgery was found to be same for those with adenocarcinoma and squamous cell carcinoma.

  • adenocarcinoma
  • cervical cancer
  • squamous cell carcinoma
  • survival

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.